Vertex announces UK approval for CASGEVY™
Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for...
read DetailsModality Solutions, a privately-held company that delivers integrated cold chain management solutions for highly regulated industries, has named Brian Brazill Consulting Engineer.
Houston, Tex. February 17, 2015 — Modality Solutions, a company that delivers integrated cold chain management systems for highly regulated industries, is pleased to announce it has hired Brian Brazill as a consulting engineer. In his position with Modality Solutions, Brazill programs and runs one of the company’s signature cold chain industry services — its Advantage Transport Simulation Laboratory™.
Modality Solutions has validated to current cGMP standards the only independent, third-party, multi-modal transport simulation laboratory in the world. It allows clients to concurrently study the impact of the following five environmental hazards: temperature, humidity, pressure, shock and vibration on the critical-to-quality attributes of products.
Prior to joining the company, Brazill attended Purdue University where he received his degree in Chemical Engineering. While at Purdue, he was on the 2014 AIChE Chem-E-Car Team. He assisted in the design of a model car that runs on thermoelectric generators. In addition, Brazill served as an engineering intern for Northern Indiana Public Service Company (NIPSCO). In this position he collected field data from utility pipelines regarding the cathodic protection from corrosion and conducted remedial studies on pipelines which did not test within acceptable boundaries for protection.
Brazill also served as an intern at Dow AgroSciences LLC, a wholly owned subsidiary of the Dow Chemical Company specializing in not only agricultural chemicals such as pesticides, but also seeds and biotechnology solutions. While at Dow, Brian supervised a team performing field studies and a variety of other activities, such as maintaining the integrity of test fields through elimination of weeds, rogue plants, and plants with genetic anomalies.
In his current Modality Solutions’ consulting engineer position, Brazill has mastered the laboratory’s SolidWorks, a 3D software tool that enables him to create, simulate, publish, and manage data. His observational skills help him evaluate crucial client product design issues and come up with creative solutions. One simulated transport study generates data that would take 100 actual shipments to achieve. Brian works together with clients to help them design products better, faster, and more cost-effectively. His responsibilities also include completing client protocols and reports. Brazill is a member of the AlChE (American Institute of Chemical Engineers).
Most recently, Brazill explained and demonstrated the Advantage Transport Simulation Laboratory™ software at the 12th Annual Cold Chain GDP & Temperature Management Logistics Global Forum during the conference’s technology demo drive session.
“We are pleased to have Brian join our team. His observational skills and attention to detail allow him to evaluate customer issues and provide innovative solutions,” said Modality Solutions President Gary Hutchinson. “He brings his study and passion in chemical engineering to the study of environmental stresses on biologics and vaccines, diagnostics, solid oral formulations, and combination medical devices during each stage of the development process.”
For more information about Modality Solutions, visit http://www.modality-solutions.com.
About Modality Solutions
Founded in 2011 Modality Solutions delivers integrated cold chain management solutions for highly regulated industries. Its Advantage Transportation Simulation Laboratory™ helps companies test the effects of transportation environmental hazards on their formulations. Key areas of service are: ensure regulatory compliance; deliver cold chain thermal packaging design / qualification and controlled-environment logistics solutions; conduct transport simulation testing; decrease development cycle times for a faster route-to-market; and develop transport validation strategies to support global regulatory applications. Contact Modality Solutions at (888) 219-6317 or email info@modality-solutions.com. Additional information can be found at http://www.modality-solutions.com.
Media Contact:
Susan Almon-Pesch
for Modality Solutions, LLC
(858) 205-0516
Click here to view this press release online.
Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for...
read DetailsCongratulations to Melinta Therapeutics for their FDA Approval of REZZAYO™ for the Treatment of...
read DetailsCongratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for...
read Details